Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine, N-of-One Collaborate to Translate Cancer Sequencing Data for Clinical Use

NEW YORK (GenomeWeb News) – Cancer care firm N-of-One today announced a deal with Foundation Medicine to translate sequencing data into clinically relevant information.

Under the terms of the agreement, Foundation will identify potential biomarkers using its sequencing and analytic capabilities on patient tumor samples. N-of-One will then use its PrecisionWorks platform to translate data from Foundation to link molecular changes with current information about relevant target therapies and clinical trials that may be used to guide treatment.

Financial and other terms of the deal were not disclosed.

"This collaboration represents another important step toward transforming next-generation sequencing into a decision-making tool that empowers oncologists to act rapidly and decisively in providing precision treatment strategies for their patients," Jennifer Levin Carter, founder and president of N-of-One, said in a statement.

Based in Waltham, Mass., N-of-One develops "roadmaps" to drive "highly informed clinical decision-making by linking data about the molecular variations in each patient's cancer cells with leading-edge knowledge, diagnostics, treatments, and technologies relevant to the tumor type," it said.

According to the firm, PrecisionWorks is a knowledge integration platform that integrates a molecular knowledge database, biomedical informatics, advanced knowledge synthesis capabilities, and logistics management systems.

Foundation Medicine is a molecular information firm based in Cambridge, Mass., and provides reports to oncologists to help them determine appropriate treatments for individual patients.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.